EUVIMEDEUVIMED entdecken
Open Access

Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation

Jingyun Wang, Yang Mi, Xiangdong Sun, Xia Xue, Huanjie Zhao, Mengfei Zhang, Baitong Hu, Ihtisham Bukhari, Pengyuan Zheng

Aging · 2023

DOI: 10.18632/aging.205329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Jingyun Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory for Helicobacter pylori and Microbiota and GI Cancer, Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou U…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Stomach Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conserved long non-coding RNAs (lncRNAs) have not thoroughly been studied in many cancers, including gastric cancer (GC). We have identified a novel lncRNA PTCHD4-AS which was highly conserved between humans and mice and naturally downregulated in GC cell lines and tissues. Notably, PTCHD4-AS was found to be transcriptionally induced by DNA damage agents and its upregulation led to cell cycle arrest at the G2/M phase, in parallel, it facilitated the cell apoptosis induced by cisplatin (CDDP) in GC. Mechanistically, PTCHD4-AS directly bound to the DNA mismatch repair protein MSH2-MSH6 dimer, and facilitated the binding of dimer to ATM, thereby promoting the expression of phosphorylated ATM, p53 and p21. Here we conclude that the upregulation of PTCHD4-AS inhibits proliferation and increases CDDP sensitivity of GC cells via binding with MSH2-MSH6 dimer, activating the ATM-p53-p21 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Stomach NeoplasmsMiceHumansAnimalsMutS Homolog 2 ProteinDimerizationDNA-Binding ProteinsCisplatinAtaxia Telangiectasia Mutated Proteins

Stichwörter der Autor:innen

DNA mismatch repair proteinsMSH2-MSH6cisplatingastric cancerlong non-coding RNA PTCHD4-AS

Substanzen

Tumor Suppressor Protein p53MutS Homolog 2 ProteinDNA-Binding ProteinsCisplatinMSH2 protein, humanATM protein, humanAtaxia Telangiectasia Mutated Proteins

Autor:innen und Institutionen

  • Henan Key Laboratory for Helicobacter pylori and Microbiota and GI Cancer, Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • Academy of Medical Science, Zhengzhou University, Zhengzhou 450000, China.
  • Department of Gastroenterology, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.

Zitieren

APA

Wang, J., Mi, Y., Sun, X., Xue, X., Zhao, H., Zhang, M., Hu, B., Bukhari, I., & Zheng, P. (2023). Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation. Aging. https://doi.org/10.18632/aging.205329

Vancouver

Wang J, Mi Y, Sun X, Xue X, Zhao H, Zhang M, et al. Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation. Aging. 2023. doi:10.18632/aging.205329

BibTeX
@article{Wang2023,
  author = {Wang, Jingyun and Mi, Yang and Sun, Xiangdong and Xue, Xia and Zhao, Huanjie and Zhang, Mengfei and Hu, Baitong and Bukhari, Ihtisham and Zheng, Pengyuan},
  title = {Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.205329}
}
Kostenlos starten →